We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$763M
AUM Growth
+$25.6M
Cap. Flow
+$12.4M
Cap. Flow %
1.62%
Top 10 Hldgs %
60.2%
Holding
534
New
65
Increased
123
Reduced
59
Closed
32

Sector Composition

Rank Sector Weight
1 Technology 1.73%
2 Financials 1.46%
3 Consumer Discretionary 0.93%
4 Healthcare 0.45%
5 Industrials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSGX icon
226
Vanguard ESG International Stock ETF
VSGX
$6.74B
$36K ﹤0.01%
499
AMD icon
227
Advanced Micro Devices
AMD
$789B
$34K ﹤0.01%
157
-26
-14% -$5.84K
CLF icon
228
Cleveland-Cliffs
CLF
$6.99B
$34K ﹤0.01%
2,558
-3
-0.1% -$38
GSK icon
229
GSK
GSK
$106B
$34K ﹤0.01%
685
AGG icon
230
iShares Core US Aggregate Bond ETF
AGG
$138B
$33K ﹤0.01%
334
XLE icon
231
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$33K ﹤0.01%
735
+3
+0.4% +$134
BKNG icon
232
Booking.com
BKNG
$161B
$32K ﹤0.01%
150
COF icon
233
Capital One
COF
$134B
$32K ﹤0.01%
131
DOW icon
234
Dow Inc
DOW
$21.2B
$32K ﹤0.01%
1,352
-39
-3% -$897
KHC icon
235
Kraft Heinz
KHC
$30B
$32K ﹤0.01%
1,327
+21
+2% +$522
VGT icon
236
Vanguard Information Technology ETF
VGT
$149B
$32K ﹤0.01%
336
NOC icon
237
Northrop Grumman
NOC
$81.2B
$31K ﹤0.01%
54
UL icon
238
Unilever
UL
$136B
$31K ﹤0.01%
470
-1
-0.2% -$67
WPC icon
239
W.P. Carey
WPC
$16.4B
$31K ﹤0.01%
+476
New +$31.7K
AMT icon
240
American Tower
AMT
$80.4B
$30K ﹤0.01%
+170
New +$30.9K
AZN icon
241
AstraZeneca
AZN
$250B
$29K ﹤0.01%
157
D icon
242
Dominion Energy
D
$59.3B
$29K ﹤0.01%
500
MO icon
243
Altria Group
MO
$114B
$29K ﹤0.01%
500
KMI icon
244
Kinder Morgan
KMI
$68.7B
$28K ﹤0.01%
+1,010
New +$27.3K
MNST icon
245
Monster Beverage
MNST
$88.5B
$28K ﹤0.01%
360
MPC icon
246
Marathon Petroleum
MPC
$83.7B
$28K ﹤0.01%
+174
New +$32.5K
CME icon
247
CME Group
CME
$94.8B
$27K ﹤0.01%
100
GILD icon
248
Gilead Sciences
GILD
$165B
$27K ﹤0.01%
218
WM icon
249
Waste Management
WM
$91B
$27K ﹤0.01%
124
GEHC icon
250
GE HealthCare
GEHC
$32.4B
$26K ﹤0.01%
316
+299
+1,759% +$23.3K

Similar funds

Roble Belko & Company's Q4 2025 Portfolio in Review

As of Q4 2025, Roble Belko & Company held 534 positions worth $763M, up 3.5% from $738M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Roble Belko & Company's Q4 2025 filing shows 65 new, 123 increased, 59 reduced and 32 closed positions. Its largest new stake was Akre Focus ETF: 8,392 shares worth $550K. The largest sale was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, an estimated $4.26M.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 1.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q4 2025 buy was Akre Focus ETF: 8,392 shares worth $550K.
  • Roble Belko & Company added most to Vanguard Intermediate-Term Treasury ETF in Q4 2025, an estimated $3.54M increase.
  • Roble Belko & Company's biggest Q4 2025 reduction was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF, cutting an estimated $4.26M.
  • Roble Belko & Company fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $983K.
  • Roble Belko & Company's ten largest holdings make up 60% of its $763M portfolio in Q4 2025.
  • Roble Belko & Company opened 65 new positions and closed 32 in Q4 2025.
  • Roble Belko & Company's portfolio value rose 3.5% quarter-over-quarter to $763M.

Based on Roble Belko & Company's 13F filing for Q4 2025, filed 12 Jan 2026.